CATTANEO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 22.235
EU - Europa 19.786
AS - Asia 5.059
SA - Sud America 203
Continente sconosciuto - Info sul continente non disponibili 95
OC - Oceania 23
AF - Africa 16
Totale 47.417
Nazione #
US - Stati Uniti d'America 22.138
IT - Italia 6.240
SE - Svezia 3.882
IE - Irlanda 3.211
TR - Turchia 1.714
DE - Germania 1.578
CN - Cina 1.538
UA - Ucraina 1.511
SG - Singapore 1.294
GB - Regno Unito 935
FI - Finlandia 547
NL - Olanda 431
CH - Svizzera 410
RU - Federazione Russa 360
AT - Austria 277
BR - Brasile 172
VN - Vietnam 163
BE - Belgio 128
FR - Francia 98
EU - Europa 92
CA - Canada 86
IL - Israele 82
ID - Indonesia 66
JP - Giappone 50
IN - India 30
ES - Italia 25
KR - Corea 22
AU - Australia 21
HK - Hong Kong 21
RO - Romania 18
AL - Albania 16
NO - Norvegia 11
PK - Pakistan 11
PL - Polonia 11
BG - Bulgaria 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
HU - Ungheria 10
RS - Serbia 10
IR - Iran 8
LT - Lituania 8
BD - Bangladesh 7
CL - Cile 7
LU - Lussemburgo 7
MX - Messico 7
TW - Taiwan 7
IQ - Iraq 6
AR - Argentina 5
GR - Grecia 5
PE - Perù 5
ZA - Sudafrica 5
EC - Ecuador 4
EG - Egitto 4
LK - Sri Lanka 4
MT - Malta 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
IM - Isola di Man 3
LB - Libano 3
LI - Liechtenstein 3
MA - Marocco 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
EE - Estonia 2
HR - Croazia 2
IS - Islanda 2
JO - Giordania 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
GE - Georgia 1
GL - Groenlandia 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LY - Libia 1
ME - Montenegro 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 47.416
Città #
Pisa 4.509
Jacksonville 3.404
Chandler 3.259
Dublin 3.206
Boardman 2.126
Wilmington 1.347
Izmir 1.300
Ashburn 1.285
Singapore 931
Ann Arbor 928
Boston 713
Millbury 681
Düsseldorf 520
San Mateo 462
Istanbul 407
New York 400
Amsterdam 380
Bern 367
Mestre 367
Bremen 320
Lawrence 314
Ogden 295
Seattle 291
Vienna 271
Woodbridge 235
Beijing 215
Princeton 204
Washington 178
Scuola 177
Dearborn 172
Saint Petersburg 167
Dong Ket 163
Milan 136
Brussels 124
Guangzhou 122
San Paolo di Civitate 114
Helsinki 109
Shanghai 96
Los Angeles 84
Fairfield 81
Santa Clara 81
Rome 78
Wuhan 72
Holon 69
Jakarta 66
Munich 60
Norwalk 60
Toronto 57
Hefei 56
Nanjing 53
San Giuliano Terme 51
Las Vegas 45
Andover 42
Houston 41
Kunming 41
Tokyo 40
Falls Church 39
Berlin 38
Cambridge 34
Chicago 34
Bientina 33
Verona 32
Jiaxing 31
Frankfurt am Main 26
Tappahannock 26
Ferrara 24
Wuxi 24
Lausanne 23
Nanchang 23
Shenzhen 23
Jinhua 22
Livorno 22
London 22
San Diego 22
Florence 21
Padova 21
Voghera 21
Yiwu 19
Edinburgh 18
Trieste 18
Jinan 17
Seoul 15
Paris 14
Stockholm 14
Zurich 14
Fuzhou 13
Hangzhou 13
Heze 13
Shenyang 13
São Paulo 13
Zhengzhou 13
Auburn Hills 12
Centrale 12
Hanover 12
Madrid 12
Redmond 12
Cedar Knolls 11
Grevenbroich 10
Hong Kong 10
Lappeenranta 10
Totale 32.241
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.062
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration 668
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 572
Precursor and mature NGF live tracking: one versus many at a time in the axons 205
Site-specific labeling of neurotrophins and their receptors via short and versatile peptide tags 187
A new intramolecular biosensor reveals Tau conformational changes in pathological conditions 176
Activity-dependent expression of Channelrhodopsin at neuronal synapses 176
Assessment of antibody library diversity through next generation sequencing and technical error compensation 173
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 171
Ligand signature in the membrane dynamics of single TrkA receptor molecules 167
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 167
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 166
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 165
Fast-diffusing p75NTR monomers support apoptosis and growth cone collapse by neurotrophin ligands 157
Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches 156
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 156
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 152
Corrigendum: Precursor and mature NGF live tracking: one versus many at a time in the axons 151
Site-specific biotinylation of neurotrophins and their receptors by the insertion of short versatile peptide tags 150
Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells 148
An Optimized Procedure for the Site-Directed Labeling of NGF and proNGF for Imaging Purposes 148
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 145
Ligand Fingerprinting in the Membrane Dynamics of Single TrkA and P75NTR Neurotrophin Receptors 144
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 144
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 142
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies 142
Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells 141
NGF steers microglia toward a neuroprotective phenotype 139
Purification and proteomic profiling of PSD-95 intereactors at in vivo potentiated synapses 138
Structural and functional properties of mouse proNGF 136
In vivo expression of anti-tau intrabodies selected by the intrabody trap technology (ITT). 136
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 136
Mapping potentiated synapses in the hippocampus during acquisition and consolidation of a contextual fear memory 136
A functional domain on the aloha-latrotoxin molecule, distinct from the binding site, involved in cathecolamine secretion from PC12 cells: identification with monoclonal antibodies 133
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 133
TANEZUMAB, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain 132
Single Molecule Imaging and Tracking of Neurotrophins and their Receptors in Living Neuronal Cells 132
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 132
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 131
null 129
A protein silencing switch by ligand-induced proteasome targeting intrabodies 128
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 128
IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels 127
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 127
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 127
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells 127
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 126
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate 126
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 125
Temperature affects longevity and age-related locomotor and cognitive decay in the short-lived fish Nothobranchius furzeri 123
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 123
Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri 122
A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites 122
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 121
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 121
Single molecule tracking and spectroscopy unveils molecular details in function and interactions of membrane receptors 121
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 120
A new mechanism for Alzheimer Neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 119
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 118
The role of Nerve Growth Factor in development and in ALzheimer's disease 118
Kinetic dynamics of a kinase-phosphatase network 117
RACK1 Is a Ribosome Scaffold Protein for beta-actin mRNA/ZBP1 Complex 117
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 117
Novel recombinant antibodies against AD biomarkers linked to neurotrophin signaling as potential diagnostic tools. 116
Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study 116
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 116
Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice 116
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 116
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 116
Novel generation of neutralizing antibodies against beta-Amyloid peptide 114
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 114
'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants 114
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 114
Conformational targeting of intracellular Amyloid-beta oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum 114
“Annual fishes of the genus Nothobranchius as a model system for aging research” 113
Thymocytes as potential target cells for nerve growth factor 113
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 113
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 113
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 113
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 112
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 112
Involvement of NGF in early stages of chick embryo development 112
A new generation of NGF-based therapy for Alzheimer’s disease 112
Method for the humanization of antibodies and humanized antibodies thereby obtained 111
In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an “undruggable” class of disease targets 111
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 111
Patterns of discharge of simple and complex visual cortical cells. 110
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 109
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 109
Intranasal delivery of therapeutic proteins for neurological diseases 109
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 108
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 108
TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor 108
Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat 108
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 108
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 108
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 107
A critical period in the sensitivity of basal forebrain cholinergic neurones to NGF deprivation 107
Simulations of signal transduction in PC12 cells 106
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 106
Totale 15.817
Categoria #
all - tutte 206.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.150 0 0 0 0 0 139 774 146 490 87 485 29
2020/20216.222 492 41 1.183 39 462 517 307 490 501 1.146 347 697
2021/20223.691 387 30 40 241 245 67 82 336 247 203 126 1.687
2022/202315.413 1.024 827 600 1.087 925 1.530 9 3.998 4.737 91 241 344
2023/20244.857 793 128 507 144 283 990 186 200 599 170 36 821
2024/20257.717 2.304 385 657 1.976 2.122 273 0 0 0 0 0 0
Totale 48.103